Home About Cytheris Corporate Overview Executive Management Board of Directors Clinical Advisory Board Academic Partners History Science Portfolio Overview Interleukin-7 NKT Ligands Pipeline & Products Development Pipeline IL-7 in Oncology IL-7 in HIV IL-7 in HCV NKT Ligands Intellectual Property Manufacturing Clinical Trials Clinical Trials Overview IL-7 Oncology Trials IL-7 HIV Trials IL-7 HCV Trials Other IL-7 Trials Business Development News Room Press Releases Calendar of Events Investors Careers Contact Us

DOWNLOAD CORPORATE FACT SHEET (PDF) DOWNLOAD CORPORATE PRESENTATION (PDF)

Press Releases 2008
June 26, 2008
	Cytheris Announces Publication of IL-7 Oncology Data in The Journal of Experimental Medicine
	FR
April 23, 2008
	Cytheris Announces New Phase I Study of Interleukin-7 As Immunotherapy In Treatment of Bone Marrow or Peripheral Blood Stem Cell Transplant Patients
	FR
March 26, 2008
	Laureate Announces Second Manufacturing Agreement with Cytheris
	FR
February 13, 2008
	Cytheris Announces 48-Week Results of Phase I/II Study Showing Administration of Interleukin-7(IL-7) Significantly Improves CD4 T-Cell Counts in Chronically Infected HIV-1 Patients
	FR